Basics Gossamer Bio, Inc. IPO Date: February 4, 2019 Sector: Healthcare Industry: Biotech Market Cap: $668.5M Activated in VL: True Average Daily Range Avg Daily Range: $0.26 | 3.56% Avg Daily Range (30 D): $0.09 | 4.35% Avg Daily Range (90 D): $0.06 | 3.95% Institutional Daily Volume Avg Daily Volume: 1.13M Avg Daily Volume (30 D): 3.24M Avg Daily Volume (90 D): 2.2M Trade Size Avg Trade Size (Sh.): 176 Avg Trade Size (Sh.) (30 D): 274 Avg Trade Size (Sh.) (90 D): 245 Institutional Trades Total Inst.Trades: 1,258 Avg Inst. Trade: $1.48M Avg Inst. Trade (30 D): $2.83M Avg Inst. Trade (90 D): $3.94M Avg Inst. Trade Volume: .26M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.72M Avg Closing Trade (30 D): $.53M Avg Closing Trade (90 D): $6.99M Avg Closing Volume: 327.8K     News Aug 14, 2025 @ 5:00 PM Pulmonary Hypertension associated with Interstitia... Source: Delveinsight Jan 14, 2025 @ 6:00 PM Evolving Landscape of Cardiology Segment: Key Mark... Source: Delveinsight Dec 2, 2024 @ 12:30 PM XOMA Royalty Acquires Pulmokine for $20 Million Ad... Source: Globe Newswire Jun 25, 2024 @ 6:39 PM Gossamer Bio's Clean Safety Profile Differentiates... Source: Vandana Singh May 19, 2024 @ 10:35 AM Wall Street Breakfast: The Week Ahead Source: Wall Street Breakfast Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.62 $-.17 $-.16 Diluted EPS $-.62 $-.17 $-.16 Revenue $ 40.24M $ 11.49M $ 9.89M Gross Profit $ $ $ Net Income / Loss $ -138.74M $ -38.27M $ -36.64M Operating Income / Loss $ -145.62M $ -38.77M $ -36.81M Cost of Revenue $ $ $ Net Cash Flow $ -60.77M $ -2.84M $ -17.16M PE Ratio